Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery, an observational cohort study

  • Alonso, María|||0000-0001-6053-4870
  • Popova, Ekaterine|||0000-0002-8781-9873
  • de Miguel, Marcos|||0000-0003-4972-4280
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • González-Tallada, Anna|||0000-0001-6509-6777
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Jauregui, Alberto
  • Trujillo Reyes, Juan Carlos|||0000-0002-3370-0869
  • Martín-Grande, Ascensión
  • Martínez Téllez, Elisabeth|||0000-0002-5144-2963
  • Parera Ruiz, Ana
  • Planas Llovet, Georgina
  • Trujillo, Laura
  • Butron, Dina
  • Sola Roca, Judit
  • Nadal Clanchet, Miriam de|||0000-0002-4559-2463
BACKGROUND: Perioperative myocardial injury (PMI) is a common complication following non-cardiac, particularly thoracic, surgery and is associated with increased cardiovascular risk. Although guidelines recommend cardiac biomarker monitoring to detect PMI, its implementation in routine clinical practice remains limited. OBJECTIVE: To evaluate the combined use of high-sensitivity cardiac troponin I (hs-cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting major adverse cardiovascular events (MACE) following elective thoracic surgery, and to determine whether NT-proBNP provides incremental prognostic value beyond hs-cTnI alone. DESIGN: Multicentre observational cohort study. SETTING: Conducted between February 2021 and November 2023 in three Spanish tertiary hospitals. PARTICIPANTS: Patients aged ≥45 years scheduled for elective thoracic surgery involving lung resection (pneumonectomy, lobectomy, bilobectomy or segmentectomy) under general anaesthesia. Exclusion criteria included urgent or non-thoracic surgery, active infection or sepsis and a history of severe heart failure (ejection fraction <30%). MAIN OUTCOME MEASURES: Combined measurement of hs-cTnI and NT-proBNP at baseline (preoperatively) and at 24 and 48 hours postoperatively.PMI was defined as hs-cTnI ≥45 ng/L at 24 and/or 48 hours or a ≥20% increase from baseline in patients with elevated preoperative concentrations. RESULTS: Among 475 patients, PMI occurred in 11.8%. PMI had higher rates of prior stroke (12.5% vs 2.9%; p=0.004), smoking history (85.7% vs 64.0%; p=0.001) and severe renal dysfunction (7.1% vs 0.7%; p=0.001), with similar Revised Cardiac Risk Index distribution. Patients with PMI also had greater postoperative elevations of hs-cTnI and NT-proBNP (p<0.001), longer surgeries (3.5 hours vs 2.7 hours; p<0.001) and more frequent lobectomy/bilobectomy (64.3% vs 50.4%; p<0.001). Robotic-assisted thoracic surgery (RATS) was associated with increased PMI risk (OR 2.29; p=0.019). Among 49 patients (10.3%) with dual postoperative elevation of hs-cTnI and NT-proBNP, cardiovascular comorbidities were common (hypertension 81.6%, smoking history 85.7%, stroke 14.3%), and most procedures were minimally invasive (video-assisted thoracic surgery 61.2%, RATS 24.5%), with a median duration of 3 hours 42 min. MACE occurred in 18.4% of this group, indicating a substantially elevated risk than isolated or no biomarker elevations. At 30 days, patients with PMI had higher MACE (14.3% vs 3.3%; p<0.001), mortality (3.6% vs 0.7%; p=0.049) and new-onset arrhythmias (5.3% vs 0.2%; p<0.001), particularly atrial fibrillation (7.1% vs 1.7%; p=0.011). Dual biomarker elevation was associated with the highest MACE risk (15.2%), representing a twofold to threefold increase over single biomarkers. CONCLUSIONS: Combined hs-cTnI and NT-proBNP assessment improves perioperative cardiovascular risk stratification beyond ischaemia. TRIAL REGISTRATION NUMBER: NCT04749212.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Study protocol for an observational cohort evaluating incidence and clinical relevance of perioperative elevation of high-sensitivity troponin I and N-terminal pro-brain natriuretic peptide in patients undergoing lung resection

  • Alonso Alonso, Maria
  • Martin-Grande, Ascencion
  • Pérez Vélez, Javier
  • Trujillo-Reyes, Juan Carlos
  • Gajate, Luis
  • De Miguel Negro, Marcos
  • González Tallada, Anna
  • Nadal Clanchet, Miriam de
  • Popova, Ekaterine
Perioperative; Lung resection, Perioperatorio; Resección pulmonar, Perioperatori; Resecció pulmonar, Introduction Myocardial injury after non-cardiac surgery has been defined as myocardial injury due to ischaemia, with or without additional symptoms or ECG changes occurring during or within 30 days after non-cardiac surgery and mainly diagnosed based on elevated postoperative cardiac troponin (cTn) values. In patients undergoing thoracic surgery for lung resection, only postoperative cTn elevations are seemingly not enough as an independent predictor of cardiovascular complications. After lung resection, troponin elevations may be regulated by mechanisms other than myocardial ischaemia. The combination of perioperative natriuretic peptide measurement together with high-sensitivity cTns may help to identify changes in ventricular function during thoracic surgery. Integrating both cardiac biomarkers may improve the predictive value for cardiovascular complications after lung resection. We designed our cohort study to evaluate perioperative elevation of both high-sensitivity troponin I (hs-TnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients undergoing lung resection and to establish a risk score for major cardiovascular postoperative complications. Methods and analysis We will conduct a prospective, multicentre, observational cohort study, including 345 patients undergoing elective thoracic surgery for lung resection. Cardiac biomarkers such as hs-TnI and NT-proBNP will be measured preoperatively and at postoperatively on days 1 and 2. We will calculate a risk score for major cardiovascular postoperative complications based on both biomarkers’ perioperative changes. All patients will be followed up for 30 days after surgery. Ethics and dissemination All participating centres were approved by the Ethics Research Committee. Written informed consent is required for all patients before inclusion. Results will be disseminated through publication in peer-reviewed journals and presentations at national or international conference meetings., This work was supported by a research grant number: ‘PI20/00154’ from the Instituto de Salud Carlos III (co-funded by the European Regional Development Fund ‘Una manera de hacer Europa’).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Study protocol for an observational cohort evaluating incidence and clinical relevance of perioperative elevation of high-sensitivity troponin I and N-terminal pro-brain natriuretic peptide in patients undergoing lung resection

  • Alonso, María|||0000-0001-6053-4870
  • Popova, Ekaterine|||0000-0002-8781-9873
  • Martín-Grande, Ascensión
  • Pérez-Vélez, Javier
  • Trujillo Reyes, Juan Carlos|||0000-0002-3370-0869
  • Gajate, Luis
  • de Miguel, Marcos|||0000-0003-4972-4280
  • González-Tallada, Anna|||0000-0001-6509-6777
  • Martínez Téllez, Elisabeth|||0000-0002-5144-2963
  • Cladellas-Gutierrez, Esther
  • Planas Llovet, Georgina
  • de Pablo, Angélica
  • Parise, Diego
  • Candela-Toha, Angel|||0000-0002-5681-392X
  • Nadal Clanchet, Miriam de|||0000-0002-4559-2463
INTRODUCTION: Myocardial injury after non-cardiac surgery has been defined as myocardial injury due to ischaemia, with or without additional symptoms or ECG changes occurring during or within 30 days after non-cardiac surgery and mainly diagnosed based on elevated postoperative cardiac troponin (cTn) values. In patients undergoing thoracic surgery for lung resection, only postoperative cTn elevations are seemingly not enough as an independent predictor of cardiovascular complications. After lung resection, troponin elevations may be regulated by mechanisms other than myocardial ischaemia. The combination of perioperative natriuretic peptide measurement together with high-sensitivity cTns may help to identify changes in ventricular function during thoracic surgery. Integrating both cardiac biomarkers may improve the predictive value for cardiovascular complications after lung resection. We designed our cohort study to evaluate perioperative elevation of both high-sensitivity troponin I (hs-TnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients undergoing lung resection and to establish a risk score for major cardiovascular postoperative complications. METHODS AND ANALYSIS: We will conduct a prospective, multicentre, observational cohort study, including 345 patients undergoing elective thoracic surgery for lung resection. Cardiac biomarkers such as hs-TnI and NT-proBNP will be measured preoperatively and at postoperatively on days 1 and 2. We will calculate a risk score for major cardiovascular postoperative complications based on both biomarkers' perioperative changes. All patients will be followed up for 30 days after surgery. ETHICS AND DISSEMINATION: All participating centres were approved by the Ethics Research Committee. Written informed consent is required for all patients before inclusion. Results will be disseminated through publication in peer-reviewed journals and presentations at national or international conference meetings. TRIAL REGISTRATION NUMBER: NCT04749212.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Study protocol for an observational cohort evaluating incidence and clinical relevance of perioperative elevation of high-sensitivity troponin I and N-terminal pro-brain natriuretic peptide in patients undergoing lung resection

  • Alonso Alonso, Maria
  • Martin-Grande, Ascencion
  • Pérez Vélez, Javier
  • Trujillo-Reyes, Juan Carlos
  • Gajate, Luis
  • De Miguel Negro, Marcos
  • González Tallada, Anna
  • Nadal Clanchet, Miriam de
  • Popova, Ekaterine
Perioperative; Lung resection, Perioperatorio; Resección pulmonar, Perioperatori; Resecció pulmonar, Introduction Myocardial injury after non-cardiac surgery has been defined as myocardial injury due to ischaemia, with or without additional symptoms or ECG changes occurring during or within 30 days after non-cardiac surgery and mainly diagnosed based on elevated postoperative cardiac troponin (cTn) values. In patients undergoing thoracic surgery for lung resection, only postoperative cTn elevations are seemingly not enough as an independent predictor of cardiovascular complications. After lung resection, troponin elevations may be regulated by mechanisms other than myocardial ischaemia. The combination of perioperative natriuretic peptide measurement together with high-sensitivity cTns may help to identify changes in ventricular function during thoracic surgery. Integrating both cardiac biomarkers may improve the predictive value for cardiovascular complications after lung resection. We designed our cohort study to evaluate perioperative elevation of both high-sensitivity troponin I (hs-TnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients undergoing lung resection and to establish a risk score for major cardiovascular postoperative complications. Methods and analysis We will conduct a prospective, multicentre, observational cohort study, including 345 patients undergoing elective thoracic surgery for lung resection. Cardiac biomarkers such as hs-TnI and NT-proBNP will be measured preoperatively and at postoperatively on days 1 and 2. We will calculate a risk score for major cardiovascular postoperative complications based on both biomarkers’ perioperative changes. All patients will be followed up for 30 days after surgery. Ethics and dissemination All participating centres were approved by the Ethics Research Committee. Written informed consent is required for all patients before inclusion. Results will be disseminated through publication in peer-reviewed journals and presentations at national or international conference meetings., This work was supported by a research grant number: ‘PI20/00154’ from the Instituto de Salud Carlos III (co-funded by the European Regional Development Fund ‘Una manera de hacer Europa’).